This report highlights high-priority use cases for public-private collaboration in healthcare. It stresses the need for a common vision and actions to unlock AI's full potential for global health. The report identifies key areas where AI can make a difference, including disease detection, outbreak management and medical breakthroughs.

A key conclusion from this report is that the United Kingdom is unlikely to lead in an increasingly competitive, global life science market unless it has a clear sense of the role of government within the health research ecosystem – and a mechanism to deliver policy in keeping with its role.

This paper propose a multimodal strategy for long-term COVID control — one that sets up multiple barriers of protection so that we are able to not only contain SARS-CoV-2 and eliminate COVID-19 as a major life-threatening disease, but also return to a new social and economic life.

Cutting-edge biotechnology, mainly consisting of gene editing, gene drives and gene synthesis, is developing and changing rapidly. This report examines the overall planning and governance of biotechnology around the world.

This report canvasses the extraordinary recent developments in genome sequencing and genetic engineering, which will transform all biological enterprises, including healthcare, among the most important parts of the global economy. It argues that there is a opportunity for Australia to play a leading role in a major economic and revolution with digital deliverables, capitalising on...